Literature DB >> 9789064

p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation.

A Radfar1, I Unnikrishnan, H W Lee, R A DePinho, N Rosenberg.   

Abstract

The Ink4a/Arf locus encodes p16(Ink4a) and p19(Arf) and is among the most frequently mutated tumor suppressor loci in human cancer. In mice, many of these effects appear to be mediated by interactions between p19(Arf) and the p53 tumor-suppressor protein. Because Tp53 mutations are a common feature of the multistep pre-B cell transformation process mediated by Abelson murine leukemia virus (Ab-MLV), we examined the possibility that proteins encoded by the Ink4a/Arf locus also play a role in Abelson virus transformation. Analyses of primary transformants revealed that both p16(Ink4a) and p19(Arf) are expressed in many of the cells as they emerge from the apoptotic crisis that characterizes the transformation process. Analyses of primary transformants from Ink4a/Arf null mice revealed that these cells bypassed crisis. Because expression of p19(Arf) but not p16 (Ink4a) induced apoptosis in Ab-MLV-transformed pre-B cells, p19(Arf) appears to be responsible for these events. Consistent with the link between p19(Arf) and p53, Ink4a/Arf expression correlates with or precedes the emergence of cells expressing mutant p53. These data demonstrate that p19(Arf) is an important part of the cellular defense mounted against transforming signals from the Abl oncoprotein and provide direct evidence that the p19(Arf)-p53 regulatory loop plays an important role in lymphoma induction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9789064      PMCID: PMC23757          DOI: 10.1073/pnas.95.22.13194

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Combined Hoechst 33342 and merocyanine 540 staining to examine murine B cell cycle stage, viability and apoptosis.

Authors:  S Reid; R Cross; E C Snow
Journal:  J Immunol Methods       Date:  1996-06-10       Impact factor: 2.303

Review 2.  Abl tyrosine kinase in signal transduction and cell-cycle regulation.

Authors:  J Y Wang
Journal:  Curr Opin Genet Dev       Date:  1993-02       Impact factor: 5.578

3.  RAG-1 and RAG-2 are not sufficient to direct all phases of immunoglobulin gene rearrangement in pre-B-cell lines.

Authors:  L C Wang; N Rosenberg
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

4.  Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl.

Authors:  J L Cleveland; M Dean; N Rosenberg; J Y Wang; U R Rapp
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

5.  Dominant negative MYC blocks transformation by ABL oncogenes.

Authors:  C L Sawyers; W Callahan; O N Witte
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

6.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Authors:  M Serrano; G J Hannon; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

7.  An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement.

Authors:  Y Y Chen; L C Wang; M S Huang; N Rosenberg
Journal:  Genes Dev       Date:  1994-03-15       Impact factor: 11.361

8.  Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition.

Authors:  J Koh; G H Enders; B D Dynlacht; E Harlow
Journal:  Nature       Date:  1995-06-08       Impact factor: 49.962

9.  Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.

Authors:  J Lukas; D Parry; L Aagaard; D J Mann; J Bartkova; M Strauss; G Peters; J Bartek
Journal:  Nature       Date:  1995-06-08       Impact factor: 49.962

10.  Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene.

Authors:  C L Sawyers; J McLaughlin; O N Witte
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more
  50 in total

1.  Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions.

Authors:  J H Dannenberg; A van Rossum; L Schuijff; H te Riele
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

2.  Role of p14(ARF) in replicative and induced senescence of human fibroblasts.

Authors:  W Wei; R M Hemmer; J M Sedivy
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

3.  Mink cell focus-forming murine leukemia virus infection induces apoptosis of thymic lymphocytes.

Authors:  F K Yoshimura; T Wang; F Yu; H R Kim; J R Turner
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Systematic genetic dissection of p14ARF-mediated mitochondrial cell death signaling reveals a key role for p21CDKN1 and the BH3-only protein Puma/bbc3.

Authors:  Philipp G Hemmati; Annika Müer; Bernd Gillissen; Tim Overkamp; Ana Milojkovic; Jana Wendt; Bernd Dörken; Peter T Daniel
Journal:  J Mol Med (Berl)       Date:  2010-04-25       Impact factor: 4.599

5.  Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpoint.

Authors:  Alexander P Miceli; Anthony J Saporita; Jason D Weber
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

6.  ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF.

Authors:  Abhishek Datta; Jayita Sen; Jussara Hagen; Chandrashekhar K Korgaonkar; Michael Caffrey; Dawn E Quelle; Douglas E Hughes; Timothy J Ackerson; Robert H Costa; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

7.  Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia.

Authors:  Nabeel Bardeesy; Jeffrey Morgan; Manisha Sinha; Sabina Signoretti; Shefali Srivastava; Massimo Loda; Glenn Merlino; Ronald A DePinho
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

8.  P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3.

Authors:  Abdessamad Zerrouqi; Beata Pyrzynska; Maria Febbraio; Daniel J Brat; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

9.  Dual inactivation of RB and p53 pathways in RAS-induced melanomas.

Authors:  N Bardeesy; B C Bastian; A Hezel; D Pinkel; R A DePinho; L Chin
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

10.  NF-kappaB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression.

Authors:  Yukio Nakamura; Raelene J Grumont; Steve Gerondakis
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.